10-12 October, 2017
Frankfurt, Germany

Pre Conference Workshop A
Tuesday 10th October, 2017

10.00 - 13.00
Effectively Build Entry Strategies into the European NASH Market

With a continually growing patient population and no approved treatments, NASH presents a huge unmet clinical need. Drug developers are racing to bring an effective therapeutic to market as
quickly as possible. However, developing a robust market entry strategy for Europe is not without its challenges. Join your peers and industry leading experts at this workshop to learn how to navigate the European drug development landscape.

Attend this expert led workshop to:

  • Gain a comprehensive understanding of the drivers of NASH disease and challenges ahead in bringing a drug to market in the European landscape.
  • Quantify the enormity of the clinical and economic burdens of NAFLD/NASH, which will likely increase as the incidence of NAFLD continues to rise.
  • Predict what the next 12 months hold for NASH drug development in Europe.

Workshop Leader: George O’Rourke, Managing Director, GO Biotech Consulting